Inflammatix Funding: $200M Raised, Investors & Rounds

Inflammatix funding overview

Inflammatix is a Biotech company based in Palo Alto, California. Inflammatix has raised $200M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Investors on record include OSF Ventures, D1 Capital Partners, Think.Health, Northpond Ventures, Khosla Ventures, Stanford-StartX Fund and 1 others. 7 distinct backers are named across the disclosed rounds.

Inflammatix at a glance

Total raised: $200M
Industry: Biotech
Headquarters: Palo Alto, California
Notable investors: OSF Ventures, D1 Capital Partners, Think.Health, Northpond Ventures, Khosla Ventures, Stanford-StartX Fund, DARPA

Frequently asked about Inflammatix funding

How much has Inflammatix raised?: Inflammatix has raised $200M in total disclosed funding across the rounds on record.
Who has invested in Inflammatix?: OSF Ventures, D1 Capital Partners, Think.Health, Northpond Ventures, Khosla Ventures, Stanford-StartX Fund are named among the investors backing Inflammatix.
What was the latest Inflammatix funding round?: No round stage has been disclosed for Inflammatix.
Where is Inflammatix based?: Inflammatix is based in Palo Alto, California.
What sector does Inflammatix operate in?: Inflammatix is tracked under Biotech from Palo Alto, California, with $200M in disclosed funding.

Every Inflammatix figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare Biotech companies in Palo Alto at a similar stage.

Inflammatix Funding: $200M Raised, Investors & Rounds

Inflammatix funding overview

Inflammatix at a glance

Frequently asked about Inflammatix funding

Inflammatix founders (1)

Companies related to Inflammatix (40)

Browse related funding lists (6)